Physician

Amar Hamad, MD

According to 2025 Medicare claims, Amar Hamad, MD (NPI: 1598765166) practices medical oncology in the Chicago-Naperville-Schaumburg, IL market, with the plurality of this provider's patient population coming from Cook, IL. This provider's primary affiliated billing organization is AFFILIATED ONCOLOGISTS, LLC (NPI: 1225314362; TIN: 274182621) and primary practice location at 60415-2717. Hamad is affiliated with the Advocate Physician Partners Accountable Care, Inc. (ACO ID: A1033) and AMITA Health Accountable Care Organization, LLC (ACO ID: A1501), participating under the MSSP model.

Hamad's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 728 traditional Medicare patients, billed 228,914 HCPCS/CPT codes, and received $4,443,319 in Medicare payments. The top billing code was 78815 (Nuclear medicine study from skull base to mid-thigh with ct scan). Part D data shows 824 prescription claims across 192 beneficiaries totaling $2,241,274 in drug costs, led by Revlimid (Lenalidomide). DME data shows 25 claims. Open Payments data shows 247 records totaling $14,209. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,859,763 to $4,443,319. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $712,184 to $2,241,274. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $3,479 to $2,404.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	449	130,810	$1,859,763
2016	460	171,748	$2,446,667
2017	558	186,937	$2,408,274
2018	655	191,781	$2,685,841
2019	762	253,799	$3,659,980
2020	793	218,797	$3,434,822
2021	913	245,894	$3,339,596
2022	810	293,491	$3,944,799
2023	757	333,242	$4,343,321
2024	728	228,914	$4,443,319

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	150	693	$712,184
2016	126	534	$1,026,923
2017	129	512	$831,798
2018	134	619	$1,435,215
2019	98	505	$1,646,116
2020	121	816	$2,093,394
2021	133	874	$2,531,333
2022	151	699	$2,503,458
2023	227	1,399	$2,965,003
2024	192	824	$2,241,274

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	23	$3,297
2016	N/R	42	$6,168
2017	N/R	65	$5,276
2018	N/R	102	$11,535
2019	N/R	31	$1,624
2020	N/R	49	$4,585
2021	N/R	66	$8,043
2022	N/R	56	$5,064
2023	N/R	114	$16,615
2024	N/R	25	$2,658

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
78815	Nuclear medicine study from skull base to mid-thigh with ct scan	112	163	$1,287
96413	Administration of chemotherapy into vein, 1 hour or less	163	579	$103
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	377	1,286	$68
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	294	643	$13
96372	Injection of drug or substance under skin or into muscle	126	333	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	43	1,168	$696,651
Erleada	Apalutamide	22	660	$309,917
Lenvima	Lenvatinib Mesylate	13	390	$298,120
Lynparza	Olaparib	11	330	$165,436
Eliquis	Apixaban	39	1,890	$37,143

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
B4152	Enteral formula, nutritionally complete, calorically dense (equal to or greater than 1.5 kcal/ml) with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit	N	N/R	12	$1,967
A4222	Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)	N	N/R	13	$691

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	247	$14,209	Rigel Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Amar Hamad, MD?

Tedicare shows public-source Medicare data for Amar Hamad, MD (NPI 1598765166), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amar Hamad, MD have ACO affiliation data?

Amar Hamad, MD is shown with ACO affiliation data for Advocate Physician Partners Accountable Care, Inc. (MSSP, ACO ID A1033) and AMITA Health Accountable Care Organization, LLC (MSSP, ACO ID A1501).

What billing organization is linked to Amar Hamad, MD?

Amar Hamad, MD is linked to AFFILIATED ONCOLOGISTS, LLC (billing NPI 1225314362) in the available physician profile data.

Does Amar Hamad, MD have Open Payments data?

Amar Hamad, MD has 247 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.